Source: International Congress 2015 – Different data in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dejan Aleksovski (Skopje, FYROM (Macedonia)), Dejan Aleksovski, Zoran Stojanovski, Ivana Babalj Veljanovski. COPD and BMI at primary level. Eur Respir J 2015; 46: Suppl. 59, 3664

Member's Comments

No comment yet.

Related content which might interest you: Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Burden of comorbidities and NT-proBNP concentrations in stable COPD patients Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Impact of the nutritional status on pulmonary function in COPD patients Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Proteinase-inhibitor system state in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 COPD staging systems and BODE index Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013 Significance of quantitative radiological phenotypes of COPD on BODE index Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Higher BODE Index in COPD patients correlated with higher number of comorbidities Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The value of the body composition analysis on COPD patients in different groups according to BMI Source: International Congress 2014 – COPD exacerbations Year: 2014 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Differences in COPD: Smokers versus non smokers Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015